COMPARING THE CLINICAL PERFORMANCE OF ACTIVAâ?¢ BIOACTIVE COMPOSITE WITH NANOHYBRID COMPOSITE IN ABFRACTION LESIONS: A ONE YEAR CLINICAL STUDY

A ONE YEAR COMPARATIVE EVALUATION OF CLINICAL PERFORMANCE OF ACTIVAâ?¢ BIOACTIVE COMPOSITE WITH NANOHYBRID COMPOSITE IN ABFRACTION LESIONS: A RANDOMIZED CONTROL STUDY

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/10/037401

Enrollment

Registered

2021-10-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K038- Other specified diseases of hard tissues of teeth

Interventions

Intervention1: ACTIVAâ?¢ bioactive composite: Placing the restorative material on the abfraction lesions according to the manufacturers instructions after occlusal adjustments followed by recalling th

Eligibility

Inclusion criteria

Inclusion criteria: Patients who have isolated abfraction lesions with greater than 1 mm depth on the vestibular sides, associated with posterior teeth caused due to abnormal biomechanical loading forces will be selected for the study

Exclusion criteria

Exclusion criteria: Poor oral hygiene Severe or chronic periodontitis Patients with severe occlusal problems and parafunctional habits Patients with temporo mandibular joint disorders Patients who give signs and symptoms of irreversible pulpitis A known allergic reaction to any of the components of the materials used, Non-vital, fractured or visibly cracked tooth Cervical caries

Design outcomes

Primary

Measure	Time frame
Two blinded examiners will evaluate the restorations with a mouth mirror and probe at baseline, 1 month, 6 months, and 1 year by modified USPHS criteria which involves Retention, Color Match, Marginal Discoloration, Marginal Adaptation, Secondary Caries, Surface Texture, Anatomic Form, Postoperative Sensitivity and also occlusal interferences will be evaluated using Shim Stock films. Comparative evaluation of clinical performance of both the composites using modified USPHS criteriaTimepoint: Two blinded examiners will evaluate the restorations with a mouth mirror and probe at baseline, 1 month, 6 months, and 1 year by modified USPHS criteria which involves Retention, Color Match, Marginal Discoloration, Marginal Adaptation, Secondary Caries, Surface Texture, Anatomic Form, Postoperative Sensitivity and also occlusal interferences will be evaluated using Shim Stock films. Comparative evaluation of clinical performance of both the composites using modified USPHS criteria	—

Measure

Time frame

Two blinded examiners will evaluate the restorations with a mouth mirror and probe at baseline, 1 month, 6 months, and 1 year by modified USPHS criteria which involves Retention, Color Match, Marginal Discoloration, Marginal Adaptation, Secondary Caries, Surface Texture, Anatomic Form, Postoperative Sensitivity and also occlusal interferences will be evaluated using Shim Stock films. Comparative evaluation of clinical performance of both the composites using modified USPHS criteriaTimepoint: Two blinded examiners will evaluate the restorations with a mouth mirror and probe at baseline, 1 month, 6 months, and 1 year by modified USPHS criteria which involves Retention, Color Match, Marginal Discoloration, Marginal Adaptation, Secondary Caries, Surface Texture, Anatomic Form, Postoperative Sensitivity and also occlusal interferences will be evaluated using Shim Stock films. Comparative evaluation of clinical performance of both the composites using modified USPHS criteria

—

Secondary

Measure	Time frame
Patients satisfaction and satisfactory clinical performance of restorative material in abfraction lesionsTimepoint: At base line 1month 6 months and 12 months	—

Countries

India

Contacts

Public ContactDR PRATHIMA B J

K.L.E SOCIETYS INSTITUTE OF DENTAL SCIENCES

drkarale79@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026